Therapeutic Advances Redefine Treatment OutcomesThe Women’s Health Therapeutics Market encompasses a wide range of products ...

GSK acquires exclusive rights from Syndivia for an ADC targeting advanced prostate cancer in a deal up to £268 m, reinforcing ...

The global cell cryopreservation market is poised for remarkable growth over the coming years, offering a compelling story ...

Novartis will buy Avidity Biosciences for US$12 billion, gaining its RNA-based therapeutic platform and rare-disease ...

Pioneering Embodied Intelligence with Real-World Applications, Open-Source Platforms, and Global Collaboration Humanoid ...

Rising Cancer Incidence Fuels Demand for Smart Nanomedicine Solutions in Oncology CareThe Smart Cancer Nanomedicine Market ...

Impact: Immediate Savings to Requesting Rebates WATKINSVILLE, GA / ACCESS Newswire / October 28, 2025 / Rural hospitals in the 340B program are about to feel a new financial pressure. On January 1, ...

FORT LAUDERDALE, FL / ACCESS Newswire / October 28, 2025 / Momentum has a way of separating the contenders from the crowd. Sunshine Biopharma (NASDAQ:SBFM) is quickly establishing which side of that ...

MESA, ARIZONA / ACCESS Newswire / October 28, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced today that its first AI-driven mobile application, [App Name Pending Trademark], has ...

ATLANTA, GEORGIA / ACCESS Newswire / October 28, 2025 / Florence Healthcare, the leading clinical trial platform connecting pharmaceutical sponsors and research sites worldwide, announced today that ...

Mark Egerton Appointed Chairman of Panthera BiopartnersPanthera Biopartners, the UK’s leading Site Management Organisation (SMO) which runs commercial clinical trials for the pharmaceutical industry, ...

Exousia Pro is in a unique position, as only 11% of ODAs are awarded at the preclinical stage. ORLANDO, FLORIDA / ACCESS Newswire / October 28, 2025 / Exousia Pro, Inc. (formerly Marijuana, Inc.) ...